Medicus Pharma seeks orphan drug status for SkinJect in Gorlin syndrome

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. CRWV

Go back to Medicus Pharma seeks orphan drug status for SkinJect in Gorlin syndrome
(NASDAQ: MDCX) Delayed: 0.34 +0.01 (3.03%)
Previous Close $0.33    52 Week High $ 
Open $0.33    52 Week Low $ 
Day High $0.34    P/E N/A 
Day Low $0.32    EPS $ 
Volume 955,991